VIVO
Index
Log in
Search form
Home
People
Organizations
Research
Events
A Historical-Controlled, Multicenter, Double-Blind, Randomized Trial to Assess the Efficacy and Safety of Conversion to Lacosamide 400mg/day Monotherapy in Subjects with Partial-Onset Seizures, Schwarz Pharma.
Grant
Affiliation
Affiliation
contributor
Calder, Christopher
Suib-investigator
- 2007